Optimising multi pronged drug intercepts in AMD


Review Article

Author Details : Sunil Chaudhry*

Volume : 7, Issue : 2, Year : 2020

Article Page : 64-72

https://doi.org/10.18231/j.agems.2020.010



Suggest article by email

Abstract

Age-related macular degeneration (AMD) is the most common cause of blindness in the elderly population worldwide. The clinical spectrum of AMD comprises of drusen, hyperplasia of the retinal pigment epithelium (RPE), atrophy and choroidal neovascularization (CNV). These changes affect the macula of the retina and subsequently may affect central or reading visual acuity. The pharmacological therapies include photodynamic therapy (PDT), steroids, vascular endothelial growth factor (VEGF) inhibitors, extracellular matrix(ECM) modifiers, gene therapy and nutrition supplements.

Keywords: Agerelated macular degeneration (AMD), ie2 (Tyrosineprotein kinase) anti VEGF ranibizumab bevacizumab aflibercept.


How to cite : Chaudhry S , Optimising multi pronged drug intercepts in AMD. Ann Geriatr Educ Med Sci 2020;7(2):64-72


Copyright © 2020 by author(s) and Ann Geriatr Educ Med Sci. This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 International License (creativecommons.org)



Article History

Received : 21-11-2020

Accepted : 16-12-2020

Available online : 04-02-2021


View Article

PDF File   Full Text Article


Downlaod

PDF File   XML File   ePub File


Digital Object Identifier (DOI)

Article DOI

https://doi.org/10.18231/j.agems.2020.010


Article Metrics






Article Access statistics

Viewed: 361

PDF Downloaded: 204